Sym004 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations
- Status
- TERMINATED
- Phase
- PHASE2
Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE3
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
- Status
- COMPLETED
- Phase
- N/A
Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- N/A
Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
- Status
- UNKNOWN
- Phase
- PHASE1
CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin
- Status
- TERMINATED
- Phase
- PHASE2
Sunitinib and Capecitabine for First Line Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
- Status
- COMPLETED
- Phase
- PHASE2